BioLife Plasma Services joined representatives from Georgia Department of Economic Development and Gwinnett Chamber Economic Development today to celebrate the grand opening of its plasma collection center in Gwinnett County.
A subsidiary of Baxalta US, Inc., BioLife Plasma Services is an industry leader in operating high-quality plasma donation centers throughout the U.S. The plasma collected at BioLife is processed into a variety of life-saving therapeutics, including treatment for patients with hemophilia and immune disorders and for use as blood volume replacement and tissue sealing.
“BioLife is pleased to open a new center in the Gwinnett community and we appreciate the support of residents who donate their plasma, which is used in life-saving therapies for patients,” said Michael Owens, Center Manager. “The grand opening of this location is an effort to better serve patients who rely on the lifesaving therapies processed from donated human plasma.”
“With over 400 life science companies operating in Georgia, an idea can be born, researched, tested, commercialized, produced and delivered quickly to customers around the world,” said Georgia Department of Economic Development Commissioner Chris Carr. “Today’s announcement marks another important step in the advancement of life saving therapies and social contribution. The opening of the new plasma collection center in Gwinnett County will create a significant economic impact, but what’s more, it will improve the lives of patients who suffer from life-threatening illnesses. We look forward to supporting BioLife Plasma Services as they continue to grow in Georgia.”
The company announced its expansion in February of this year and will be creating 50 new jobs, along with a $7 million capital investment. The new 15,000-square-foot facility is located at 3440 Centerville Highway in the Centerville area of Gwinnett County, and features a free supervised playroom and free wireless internet.
“We are proud to support the Georgia Life Science ecosystem that has a balanced healthcare and life science network including Hematology companies like BioLife,” said Nick Masino, Senior Vice President for Gwinnett Chamber Economic Development and Partnership Gwinnett. “It is exciting to call Gwinnett home to such strong Hematology companies including ADMA Biologics and Qualtex Laboratories.”
“We are thrilled that BioLife has chosen to grow in Gwinnett,” said Gwinnett County Board of Commissioners Chair Charlotte Nash. “With Gwinnett’s skilled workforce and significant infrastructure, companies like BioLife are able to successfully grow and expand their business with confidence.”
For more information on the donation process and to locate additional centers, please visit the BioLife website, www.biolifeplasma.com.
For more information, or to learn how to get involved in local economic development efforts, please visit www.gwinnetteconomicdevelopment.com .
BioLife Plasma Services is part of Baxalta US Inc. the principal domestic operating subsidiary of Baxalta Incorporated. BioLife Plasma Services is an industry leader in the collection of plasma that is processed into life-saving plasma-based therapies. BioLife operates numerous state-of-the-art plasma collection facilities throughout the United States and Austria. BioLife is committed to safety. In order to provide quality service and a high level of safety to donors, as well as the patients who receive the life-saving therapeutics that are made from plasma, the company is licensed by and/or complies with requirements from the Plasma Protein Therapeutics Association (PPTA), the U.S. Food and Drug Administration (FDA), Occupational Safety and Health Administration (OSHA), Environmental Protection Agency (EPA) and other state and local regulations.
Baxalta Incorporated (NYSE: BXLT) is a $6 billion global biopharmaceutical leader developing, manufacturing and commercializing therapies for orphan diseases and underserved conditions in hematology, oncology and immunology. Driven by passion to make a meaningful impact on patients’ lives, Baxalta’s broad and diverse pipeline includes biologics with novel mechanisms and advanced technology platforms such as gene therapy. Launched in 2015, following separation from Baxter International, Baxalta’s heritage in biopharmaceuticals spans decades. Baxalta’s therapies are available in more than 100 countries and it has advanced biological manufacturing operations across 12 facilities, including state-of-the-art recombinant production and plasma fractionation. Headquartered in Northern Illinois, Baxalta employs 16,000 employees worldwide.
About Gwinnett Chamber Economic Development
Gwinnett Chamber Economic Development globally markets Gwinnett as the premier location in metro Atlanta and the State of Georgia for growing and conducting business. By encouraging investment and trade into the county through relocation and expansion assistance, the organization works with local and regional partners to bring advanced manufacturing, corporate headquarters, health sciences and services, information technology and supply chain management to the community. Home to FORTUNE 500 and 1000 companies, Gwinnett County hosts a wide range of businesses from industry giants, to international companies and homegrown startups. Success lives here- www.gwinnetteconomicdevelopment.com.
Haley Tolbert | email@example.com | 770.232.1174